Contact us
Home / News Center / Business / Page 2

Business

Filters
Filters
Category
Search
Show (31)
Cancel
news15_Bora Pharmaceuticals_June 20, 2024_1523x510
Business

Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility

Bora Pharmaceuticals announced it entered into an agreement for Emergent
news16_Bora Wins_April 11, 2024_1523x510
Business

Bora Wins Presidential Innovation Award, Award Prize Donation to Benefit Those Impacted by Earthquake

The Office of the President Taiwan announced the winners of
news17_Bora Pharmaceuticals_April 2, 2024_1523x510
Business

Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith

Bora Pharmaceuticals announced it has completed the acquisition of Upsher-Smith
news18_SunWay Biotech_March 18, 2024_1523x510
Business

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

SunWay Biotech and Gnosis by Lesaffre has announced a strategic
Upsher-Smith
Business

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472),
news21_Bora Pharmaceuticals_December 11, 2023_1523x510
Business

Bora Pharmaceuticals Celebrates Integration with SunWay Biotech, Embarking on a Global Journey

Taipei, Taiwan - December 11, 2023 – Last Friday, Bora
news13_Bora Recognized_December 8, 2023_1523x510
Business

Bora Recognized at “2023 Most Outstanding Company of the Year Awards.” Ceremony Attended by President Tsai Ing-wen

Bora Pharmaceuticals honored at the "2023 Most Outstanding Company of
Taoyuan unveiling
Business

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in
news28_Bora Pharmaceuticals_July 28, 2023_1523x510
Business

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023

Bora Pharmaceuticals is Awarded Outstanding Company of the Year at

9dab371d8d3507a5ed312a0f45bcb7dc
Business

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in
image-missing
Business

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Establishing a lead position in Taiwan's CDMO sector
news26_Bora Pharmaceuticals_May 10, 2022_1523x510
Business

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market

Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora

Bora

Contact

Address

  • 6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan
Youtube Linkedin

Quick Links

Copyright © 2025 Bora Pharmaceuticals. Developed by Engage.
Privacy Policy